Both in Pharmaceuticals
Amylyx Pharmaceuticals vs Organon &
Over the past year AMLX returned +105.5% and OGN returned +106.1%; their daily moves had a correlation of 0.04.
AMLX +105.5% OGN +106.1%Growth of $1, one year, split-adjusted
| Metric | AMLX | OGN |
|---|---|---|
| Price | $27.95 | $13.83 |
| Market cap | $3.51B | $3.63B |
| Today | −3.15% | −0.07% |
| 1 month | +0.6% | +0.8% |
| 6 months | +69.8% | +4.3% |
| Year to date | +131.4% | +92.9% |
| 1 year | +98.9% | +110.5% |
| Revenue growth (YoY) | — | −1.7% |
| Gross margin | — | 55.2% |
| Net margin | — | 10.4% |
| P/E (TTM) | — | 17.1× |
| Price / sales | — | 0.6× |
| Net cash | $250.8M | -$7.10B |
| Dividend yield | — | 0.58% |
| Volatility (60d) | 112.3% | 2.9% |
| Short % of float | 13.7% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).